SCHEMBL6472021

SCHEMBL6472021

CCOn1c2ccccc2c2c(Br)cccc21

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
PKM P14618 1/20 0.40
ALDH1A1 P00352 6/20 0.39
TSHR P16473 1/20 0.39
CNR2 P34972 4/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CNR1 P21554 2/20 0.35
GRM2 Q14416 2/20 0.34
KRAS P01116 1/20 0.33
CYP1B1 Q16678 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6470929 0.81 SMN1; SMN2 (0.41) ALDH1A1CNR2KDM4EMEN1KMT2A
SCHEMBL6531635 0.76 LMNA (0.42) LMNAPKMALDH1A1TSHRKDM4E
SCHEMBL18566674 0.72 GPR3 (0.58) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL15400211 0.68 CNR2 (0.56) ALDH1A1CNR2KDM4EMEN1KMT2A
SCHEMBL28824473 0.66 GPR3 (0.43) LMNAPKMALDH1A1TSHRKDM4E
SCHEMBL3049158 0.66 L3MBTL1 (0.61) ALDH1A1TSHRKDM4EMEN1KMT2A
SCHEMBL29446458 0.66 L3MBTL1 (0.61) ALDH1A1TSHRKDM4EMEN1KMT2A
SCHEMBL31384383 0.66 L3MBTL1 (0.61) ALDH1A1TSHRKDM4EMEN1KMT2A
SCHEMBL10277286 0.66 POLB (0.65) LMNAALDH1A1TSHRCNR2KDM4E
SCHEMBL19163665 0.65 PDE7A (0.42) LMNAALDH1A1TSHRCNR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554262-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Glenmark Pharmaceuticals Limited (IN) 2005-07-20 EP disclosed
WO-2004037805-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD. (US) 2004-05-06 WO disclosed